Abstract
Integration of the genome of the human immunodeficiency virus (HIV) into that of the host genome is catalyzed by HIV integrase (IN) and is an essential step in HIV-1 life cycle. Therefore, drug discovery efforts have been undertaken to identify selective IN inhibitors with the goal of improving the outcome of AIDS therapy using Highly Active Anti Retroviral Therapy (HAART). As computational technology has grown rapidly and is increasingly being used worldwide to accelerate the drug discovery processes, the aim of this review is to summarize the applications of the computer-aided drug design (CADD) techniques to HIV-1 IN and its inhibitors. The following applications are emphasized, including two- and three-dimensional quantitative structure activity relationships (2D/3D-QSAR), pharmacophore modeling, database searching, molecular docking, molecular dynamics simulations, and de novo methodologies.
Keywords: HIV-1 integrase, CADD, QSAR docking, molecular dynamics simulations, de novo pharmacophore modeling
Current Computer-Aided Drug Design
Title: Computational Studies of HIV-1 Integrase and its Inhibitors
Volume: 3 Issue: 3
Author(s): Nadtanet Nunthaboot, Somsak Pianwanit, Vudhichai Parasuk, Sirirat Kokpol and James M. Briggs
Affiliation:
Keywords: HIV-1 integrase, CADD, QSAR docking, molecular dynamics simulations, de novo pharmacophore modeling
Abstract: Integration of the genome of the human immunodeficiency virus (HIV) into that of the host genome is catalyzed by HIV integrase (IN) and is an essential step in HIV-1 life cycle. Therefore, drug discovery efforts have been undertaken to identify selective IN inhibitors with the goal of improving the outcome of AIDS therapy using Highly Active Anti Retroviral Therapy (HAART). As computational technology has grown rapidly and is increasingly being used worldwide to accelerate the drug discovery processes, the aim of this review is to summarize the applications of the computer-aided drug design (CADD) techniques to HIV-1 IN and its inhibitors. The following applications are emphasized, including two- and three-dimensional quantitative structure activity relationships (2D/3D-QSAR), pharmacophore modeling, database searching, molecular docking, molecular dynamics simulations, and de novo methodologies.
Export Options
About this article
Cite this article as:
Nunthaboot Nadtanet, Pianwanit Somsak, Parasuk Vudhichai, Kokpol Sirirat and Briggs M. James, Computational Studies of HIV-1 Integrase and its Inhibitors, Current Computer-Aided Drug Design 2007; 3 (3) . https://dx.doi.org/10.2174/157340907781695459
DOI https://dx.doi.org/10.2174/157340907781695459 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Emerging Immunotargets in Metastatic Renal Cell Carcinoma
Current Drug Targets The Biology and Medicinal Chemistry of Epothilones
Current Medicinal Chemistry - Anti-Cancer Agents Fork Head Transcription Factors
Current Genomics Tubulin Inhibitors: A Patent Survey
Recent Patents on Anti-Cancer Drug Discovery Immobilization and Application of Electrospun Nanofiber Scaffold-based Growth Factor in Bone Tissue Engineering
Current Pharmaceutical Design Multiple Functions of Mammalian Germinal Center Kinases
Current Chemical Biology Genetics of Bladder Malignant Tumors in Childhood
Current Genomics Review of Clinic Trials: Agents Targeting c-Met
Reviews on Recent Clinical Trials Overview of Cantharidin and its Analogues
Current Medicinal Chemistry Methylenetetrahydrofolate Reductase (MTHFR): A Novel Target for Cancer Therapy
Current Pharmaceutical Design Anti-Tumor Activity of Non-Nucleosidic Reverse Transcriptase Inhibitors
Current Pharmaceutical Design Current Status and Perspectives in Peptide Receptor Radiation Therapy
Current Pharmaceutical Design Synergistic Interaction of Telomerase-Specific Oncolytic Virotherapy and Chemotherapeutic Agents for Human Cancer
Current Pharmaceutical Biotechnology Ganoderma lucidum: A Potent Pharmacological Macrofungus
Current Pharmaceutical Biotechnology The Heat Shock Protein 90 Chaperone Complex: An Evolving Therapeutic Target
Current Cancer Drug Targets Chitosan Nanoparticles for Melanoma Cancer Treatment by Photodynamic Therapy and Electrochemotherapy Using Aminolevulinic Acid Derivatives
Current Medicinal Chemistry Synthesis of Phenanthroindolizidine Alkaloids with an Acyloxy Group at the C3 Position and their Antitumor Activities and Toxicities
Letters in Drug Design & Discovery Hereditary Papillary Renal Carcinoma Type I
Current Molecular Medicine Topoisomerase II Inhibitors and Poisons, and the Influence of Cell Cycle Checkpoints
Current Medicinal Chemistry ETS Proteins and MMPs: Partners in Invasion and Metastasis
Medicinal Chemistry Reviews - Online (Discontinued)